Drug
Gen1042
Gen1042: highest development phase Phase 1, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEN1042 NCT06057038 | Phase 1 | Malignant Solid Tumor |
Latest
No recent events.
Follow Gen1042 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.